Clinical trial reportJournal for immunotherapy of cancerPublished
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer
Regional connection
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Thomas Jefferson University. Affiliation source
- Institutions
- Bristol Myers Squibb, Thomas Jefferson University
- Counties
- Mercer County, Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal for immunotherapy of cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Colorectal Neoplasms; Pancreatic Neoplasms; Receptors, CCR5; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Receptors, CCR2
- PubMed ID
- 41571299
- PubMed Central ID
- PMC12829384
- Open access
- Yes, open
- Added to directory
- Source checked